Non Small Cell Lung Cancer

Showing NaN - NaN of 45

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non Small Cell Lung Cancer, Quality of Life, Coping Skills Trial in Boston, Danvers, Newton (Supportive Care Mobile Application,

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Supportive Care Mobile Application
  • Usual Care
  • Boston, Massachusetts
  • +2 more
Nov 2, 2021

Non Small Cell Lung Cancer, Lung Cancer Trial in Worldwide (Vandetanib, Pemetrexed)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Lung Cancer
  • Casa Grande, Arizona
  • +109 more
Oct 20, 2021

Non Small Cell Lung Cancer Trial in Boston (DCE-MRI scan, Stereotactic Body Radiation Therapy, 4D-CT scan)

Terminated
  • Non Small Cell Lung Cancer
  • DCE-MRI scan
  • +2 more
  • Boston, Massachusetts
  • +1 more
Sep 15, 2021

Melanoma, Head Neck Cancer, Non Small Cell Lung Cancer Trial in United States (Enoblituzumab, Pembrolizumab, MGA012)

Completed
  • Melanoma
  • +3 more
  • Enoblituzumab
  • +2 more
  • Scottsdale, Arizona
  • +19 more
Sep 22, 2021

Non Small Cell Lung Cancer Trial in Worldwide (HM61713)

Terminated
  • Non Small Cell Lung Cancer
  • Beverly Hills, California
  • +71 more
Jan 17, 2021

Non Small Cell Lung Cancer Trial in Worldwide (RAD001, erlotinib)

Completed
  • Non Small Cell Lung Cancer
  • Atlanta, Georgia
  • +13 more
Dec 17, 2020

Circulating Tumor DNA From LIquid Biopsy in Early Stage NSCLC

Terminated
  • Non Small Cell Lung Cancer
  • biospecimen collection
  • Atlanta, Georgia
  • +5 more
Nov 18, 2020

Non Small Cell Lung Cancer Trial in Palo Alto, Boston, New York (Afatinib)

Unknown status
  • Non Small Cell Lung Cancer
  • Palo Alto, California
  • +3 more
Jul 1, 2020

Non Small Cell Lung Cancer Trial in United States (Ponatinib)

Completed
  • Non Small Cell Lung Cancer
  • Orange, California
  • +4 more
Dec 8, 2019

Lung Cancer, Non Small Cell Lung Cancer Trial in United States (apricoxib, Placebo, Docetaxel or Pemetrexed)

Completed
  • Lung Cancer
  • Non Small Cell Lung Cancer
  • Los Angeles, California
  • +11 more
Oct 15, 2019

Non Small Cell Lung Cancer Trial in Worldwide (AZD6244, docetaxel, Placebo)

Completed
  • Non Small Cell Lung Cancer
  • Los Angeles, California
  • +63 more
May 22, 2018

Non Small Cell Lung Cancer Trial in Boston (AUY922)

Completed
  • Non Small Cell Lung Cancer
  • Boston, Massachusetts
  • +3 more
Mar 11, 2018

Non Small Cell Lung Cancer Trial in Boston (AUY922)

Completed
  • Non Small Cell Lung Cancer
  • Boston, Massachusetts
  • +3 more
Mar 5, 2018

Locally Advanced Solid Tumor, Metastatic Solid Tumor, Breast Cancer Trial in Italy, Spain, United States (MSC1936369B

Completed
  • Locally Advanced Solid Tumor
  • +5 more
  • MSC1936369B (pimasertib)
  • SAR245409 (PI3K and mTOR inhibitor)
  • Scottsdale, Arizona
  • +7 more
Jan 17, 2017

Detecting EGFR T790M Mutations From Circulating Tumor Cells

Completed
  • Non Small Cell Lung Cancer
  • Circulating tumor cell chip
  • Boston, Massachusetts
  • +3 more
Sep 23, 2016

Non Small Cell Lung Cancer Trial in Worldwide (BMS-690514, Erlotinib)

Completed
  • Non Small Cell Lung Cancer
  • New Haven, Connecticut
  • +29 more
Sep 23, 2015

Non Small Cell Lung Cancer Trial in United States (STA 9090)

Completed
  • Non Small Cell Lung Cancer
  • STA 9090
  • Tucson, Arizona
  • +20 more
Sep 18, 2014

Non Small Cell Lung Cancer Trial in Worldwide (IPI 504 plus Docetaxel, Placebo plus Docetaxel)

Completed
  • Non Small Cell Lung Cancer
  • IPI 504 plus Docetaxel
  • Placebo plus Docetaxel
  • Chandler, Arizona
  • +65 more
May 16, 2014

Non Small Cell Lung Cancer Trial in Worldwide (ARQ 197, Erlotinib, Placebo)

Completed
  • Non Small Cell Lung Cancer
  • ARQ 197
  • +2 more
  • Burbank, California
  • +37 more
Feb 22, 2013